NCT07223489 Diagnostic Journey, Patient Experience, and Disparities in the Treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System
| NCT ID | NCT07223489 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medstar Health Research Institute |
| Condition | Spinal Muscular Atrophy (SMA) |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-10-10 |
| Primary Completion | 2026-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-10-10 with a primary completion date of 2026-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluate the diagnostic journey, patient experience, and disparities in the treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System.
Eligibility Criteria
Inclusion Criteria: * SMA diagnosis, age greater than or equal to 18 years Exclusion Criteria: * Deceased
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07223489 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Spinal Muscular Atrophy (SMA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07223489 currently recruiting?
Yes, NCT07223489 is actively recruiting participants. Contact the research team at gabrielle.edwards@medstar.net for enrollment information.
Where is the NCT07223489 trial being conducted?
This trial is being conducted at Washinton, United States.
Who is sponsoring the NCT07223489 clinical trial?
NCT07223489 is sponsored by Medstar Health Research Institute. The trial plans to enroll 200 participants.